Filing Details
- Accession Number:
- 0001127602-14-026746
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-08-28 17:07:44
- Reporting Period:
- 2014-08-26
- Filing Date:
- 2014-08-28
- Accepted Time:
- 2014-08-28 17:07:44
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1585364 | Perrigo Co Plc | PRGO | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1398335 | Jeffrey Needham | C/O Perrigo Company 515 Eastern Avenue Allegan MI 49010 | Sr. Vp Commercial Business Dev | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Disposition | 2014-08-26 | 2,240 | $148.30 | 5,199 | No | 4 | S | Direct | |
| Ordinary Shares | Acquisiton | 2014-08-26 | 1,959 | $90.65 | 7,158 | No | 4 | M | Direct | |
| Ordinary Shares | Disposition | 2014-08-26 | 1,959 | $148.48 | 5,199 | No | 4 | S | Direct | |
| Ordinary Shares | Acquisiton | 2014-08-26 | 3,924 | $108.62 | 9,123 | No | 4 | M | Direct | |
| Ordinary Shares | Disposition | 2014-08-26 | 3,924 | $148.75 | 5,199 | No | 4 | S | Direct | |
| Ordinary Shares | Acquisiton | 2014-08-26 | 2,082 | $119.78 | 7,281 | No | 4 | M | Direct | |
| Ordinary Shares | Disposition | 2014-08-26 | 2,082 | $148.47 | 5,199 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Ordinary Shares | Employee Stock Option Right to Buy | Disposition | 2014-08-26 | 1,959 | $0.00 | 1,959 | $90.65 |
| Ordinary Shares | Employee Stock Option Right to Buy | Disposition | 2014-08-26 | 3,924 | $0.00 | 3,924 | $108.62 |
| Ordinary Shares | Employee Stock Option Right to Buy | Disposition | 2014-08-26 | 2,082 | $0.00 | 2,082 | $119.78 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2021-08-23 | No | 4 | M | Direct | |
| 1,962 | 2022-08-23 | No | 4 | M | Direct | |
| 4,163 | 2023-08-22 | No | 4 | M | Direct |
Footnotes
- The price in column 4 is a weighted average. The prices actually received ranged from $148.09 to $148.59. For all transactions reported in this Form 4 utilizing a weighted average price, the reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.
- The price in column 4 is a weighted average. The prices actually received ranged from $148.30 to $148.77. For all transactions reported in this Form 4 utilizing a weighted average price, the reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.
- The price in column 4 is a weighted average. The prices actually received ranged from $148.34 to $149.09. For all transactions reported in this Form 4 utilizing a weighted average price, the reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.
- The price in column 4 is a weighted average. The prices actually received ranged from $148.15 to $148.79. For all transactions reported in this Form 4 utilizing a weighted average price, the reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.
- Exercisable in 3 equal annual installments beginning 8/23/12.
- Exercisable in 3 equal annual installments beginning 8/23/13
- Exercisable in 3 equal annual installments beginning 8/22/14.
Billionaire Hedge Funds
